A Phase III, eight week randomised double-blind, double-dummy, forced titration study to compare the fixed-dose combination tablet of telmisartan 80 mg plus amlodipine 10 mg versus amlodipine 10 mg ov...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-000874-19

A Phase III, eight week randomised double-blind, double-dummy, forced titration study to compare the fixed-dose combination tablet of telmisartan 80 mg plus amlodipine 10 mg versus amlodipine 10 mg over encapsulated capsules mono-therapy as first line therapy in patients with type 2 diabetes mellitus and Stage I or II hypertension

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To demonstrate that the fixed-dose combination of telmisartan 80 mg plus amlodipine 10 mg is superior as first line therapy in reducing mean seated trough cuff systolic blood presure compared to the monotherapy of amlodipine 10 mg in patients with type 2 diabetes and Stage I or II hypertension.


Critère d'inclusion

  • type 2 diabetes and mild to moderate hypertension